Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30
Recruiting now · Phase 4
Conditions studied: Skin Quality Improvement, Photo-aged Skin, Drug Delivery Systems
In brief
Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.
Key facts
- Study ID
- NCT07376148
- Run by
- Instituto de Oftalmología Fundación Conde de Valenciana
- People needed
- 30
- Starts
- 2025-11-07
- Expected to finish
- 2026-04-30
- Last updated by the study team
- 2026-01-29
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male and female subjects, over 30 years of age, with moderate skin changes associated with elasticity, wrinkles, roughness, pigmentation, erythema, and pore size; with at least 12 points on the SASSQ scale. Fitzpatrick skin type I-III. Participants who agree to take part in the protocol
You may not qualify if…
- Fitzpatrick skin type IV-VI. Local infections or inflammatory disorders.. Neoplasms suspected of being malignant. Allergy to hyaluronic acid, ascorbic acid, and sodium DNA. Hypersensitivity to fractional CO2 laser. Pregnancy or breastfeeding. Local or systemic adverse reaction
Where it is running
- Instituto de Oftalmología F.A.P. Conde de Valenciana, I.A.P. — Mexico City, Mexico City, Mexico (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.